Aidoc has raised $150M to accelerate development of its CARE foundation model for clinical AI in radiology and beyond.
Key Details
- 1Aidoc secured $150M in funding, bringing total raised to $370M since 2016.
- 2Investors include major U.S. hospital systems and venture capital firms; $40M is a revolving credit line.
- 3Funds will accelerate CARE, a clinical-grade foundation AI model adaptable across diseases.
- 4CARE aims to cover 90% of clinically relevant diseases within three years, including cancer and cardiovascular conditions.
- 5Aidoc supports decision-making for over 45 million patients annually across 150+ health systems.
- 6Company has over 20 FDA clearances and plans significant investment via partnerships with Nvidia and AWS.
Why It Matters
Aidoc's funding enables rapid development and scaling of foundational imaging AI, with potential to cover most clinically relevant diseases and support broader, system-wide AI adoption. Such progress could shift the landscape for radiologists and health systems, impacting workflow, diagnostics, and patient outcomes.
Source
Radiology Business
Related News
•Radiology Business
NVIDIA Envisions Autonomous AI Agents Transforming Radiology
NVIDIA foresees a major shift in radiology toward autonomous AI agents and imaging systems that could revolutionize patient care.
•Radiology Business
FDA-Cleared Imaging AI Proliferates, But Reimbursement Stalls
Despite a surge in FDA-cleared radiology AI tools, very few qualify for reimbursement due to lack of supporting clinical studies.
•Radiology Business
FDA Approves 56 New AI Radiology Devices, Total Tops 1,000
FDA updates its list with 56 new AI-powered radiology devices, bringing the total to over 1,000 approved tools.